• CD38 CAR Binder Structure and Affinity Tuning

  2026-09-16

  Cheng et al. define how the CD38 CAR binders RP02 and 028 engage distinct antigen surfaces and alter CD38 enzymatic activity. Their structure-guided analysis shows that attenuating 028 affinity can reduce CAR-T fratricide while preserving antitumor cytotoxicity, offering a framework for balancing potency, selectivity, and safety.

• 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) Workflow Guide

  2026-09-16

  1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is a helper phospholipid for cationic liposomes, nucleic acid delivery systems, and related membrane-formulation workflows. This guide covers preparation, formulation controls, and troubleshooting; it should not be dissolved directly in water or treated as proof of a specific biological outcome without application-specific validation.

• Mecamylamine Hydrochloride in Gut–Brain Research

  2026-09-15

  Mecamylamine hydrochloride gives translational researchers a reversible way to test whether nicotinic acetylcholine receptor signaling links gut-derived vagal activity to brain outcomes. This article connects recent Bacteroides fragilis seizure research with practical assay design, mechanistic controls, and neuropsychiatric research strategy.

• Protoporphyrin IX: Heme, Photodynamics & Ferroptosis

  2026-09-15

  Protoporphyrin IX is a photodynamic compound and the terminal porphyrin precursor used for heme formation. Its photochemical potential supports photodynamic cancer diagnosis and therapy research, while current HCC ferroptosis evidence should not be interpreted as direct evidence for Protoporphyrin IX activity.

• PUFA-PL Biosynthesis and Rice Blast Pathogenicity

  2026-09-14

  A 2024 Mycology study connects Fad2- and Acsl4-dependent polyunsaturated phospholipid biosynthesis with ferroptotic cell death and pathogenic development in Magnaporthe oryzae. Its genetic, lipidomic, chemical-rescue, and protein-interaction analyses identify lipid peroxidation as a potential antifungal intervention point while also clarifying the limits of inferring ferroptosis from indirect markers.

• METTL16-SENP3-LTF Axis in HCC Ferroptosis

  2026-09-14

  Wang et al. identify a METTL16-SENP3-LTF signaling axis that protects hepatocellular carcinoma cells from iron-dependent lipid peroxidation and supports tumor progression. The study integrates genetic models, organoids, molecular assays, and human samples to connect m6A-dependent RNA regulation with labile iron control, suggesting a route for ferroptosis sensitization in HCC.

• DOPE Workflows for Nucleic Acid Delivery

  2026-09-13

  Discover how 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) improves endosomal escape across transfection, LNP, vaccine, and nanomedicine workflows. This guide combines formulation parameters with a lipidomics-informed framework for troubleshooting and exploratory fungal pathogenicity assays.

• Annexin-V Mapping of Cardiomyocyte Death After I/R

  2026-09-12

  This Circulation study established labeled recombinant annexin-V as an in vivo method for detecting phosphatidylserine externalization during early cardiomyocyte death after myocardial ischemia and reperfusion. By resolving the timing and magnitude of cell death in a mouse model, the work provided a practical framework for evaluating interventions intended to limit reperfusion-associated injury.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-09-12

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It generates blunt-ended products for cloning and sequencing workflows, but is not the appropriate choice when a protocol requires 3′-A overhangs or polymerase-generated sticky ends.

• Cabozantinib in RCC: Workflow & Adaptation

  2026-09-11

  Use Cabozantinib (XL184) to connect receptor tyrosine kinase inhibition with angiogenesis, phosphoproteomic remodeling, and motility phenotypes. This workflow pairs acute and chronic exposure in renal cell carcinoma models, helping researchers distinguish direct drug effects from adaptation.

• GSH and GSSG Assay Kit in Hypoxia Biology

  2026-09-11

  The GSH and GSSG Assay Kit provides a practical route to reduced glutathione detection and oxidized glutathione measurement in hypoxic tumor models. This guide translates tumor immunometabolism into sampling, normalization, and interpretation decisions for more rigorous redox state analysis.

• T0070907: A Practical PPARγ Antagonist Guide

  2026-09-10

  T0070907 is a nanomolar PPARγ antagonist for separating receptor-dependent transcription from downstream effects in adipogenesis, inflammatory foam-cell, and cancer-cell assays. This workflow-focused guide covers formulation, assay design, RXRα/PPARγ pathway testing, cell-cycle analysis, and troubleshooting.

• GRE Inhibits Melanogenesis Through CREB/MITF

  2026-09-10

  The reference study evaluates a combined glabridin, resveratrol, and ellagic acid formulation, identifying GRE as the strongest tested composition for suppressing melanin production, oxidative stress, and nitric oxide release in cell-based assays. Its value lies in connecting phenotypic endpoints with CREB/MITF pathway regulation, while also clarifying the experimental controls needed for pigmentation and inflammation studies.

• Ibuprofen as an Emerging Contaminant: Review Insights

  2026-09-09

  Jan-Roblero and Cruz-Maya’s review reframes ibuprofen as an environmental contaminant shaped by high consumption, incomplete removal, persistence, and biological effects in aquatic and soil systems. Its main practical contribution is to connect contaminant toxicology with bacterial biodegradation as a possible, but still developing, remediation strategy.

• Chlorambucil: Beyond the Viability Readout

  2026-09-09

  Chlorambucil is a nitrogen mustard alkylating agent whose DNA damage can produce growth arrest or cell death. This guide applies a time-resolved assay framework to distinguish those outcomes and improve interpretation of cancer-response experiments.

8003 records 1/534 page Next 12345 下5页 Last page